Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has ...

GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...

GlaxoSmithKline's board had responded to the broadside attack delivered by activist investor Elliott Management yesterday, saying it stands firmly behind the leadership of chief executive Emma ...

At the Financial Times (FT) Global Pharma and Biotech Summit in London on 6 November, GSK CEO Emma Walmsley addressed these concerns and underscored the critical role of the US in GSK’s operations.

Anne Wojcicki has resigned as 23andMe's CEO. She is the sister of late YouTube CEO Susan Wojcicki and the ex-wife of Sergey ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

In the least surprising news of the day, 23andMe has officially filed for bankruptcy and the CEO jumped ship — with the ...

Speaking at the CEO Times Summit in London, Walmsley highlights the U.K. pharmaceutical company's refocused R&D strategy, with investments concentrated in the U.K., U.S., and Europe. GSK ...

GSK CEO Emma Walmsley is the first woman to lead a big pharmaceutical company. At an investor conference on Tuesday, she was asked about female leadership in the industry. She responded with how ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases. During her eight years at ...